Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11151
Cadiz
CDZI
$339M
| $74.6K | ﹤0.01% |
24,623
-20,414
| -45% | -$66.4K |
|
11152
Genius Group
GNS
$34.9M
| $74.3K | ﹤0.01% |
81,861
+18,184
| +29% | +$27.3K |
|
11153
PUT
Design Therapeutics
DSGN
$955M
| $74.2K | ﹤0.01% |
13,800
-500
| -3% | -$2.35K |
|
|
NRT
11154
North European Oil Royalty Trust
NRT
$82.7M
| $74.2K | ﹤0.01% |
14,134
-7,203
| -34% | -$42K |
|
11155
CALL
The ONE Group
STKS
$54M
| $73.6K | ﹤0.01% |
20,000
-23,100
| -54% | -$92.9K |
|
11156
Shattuck Labs
STTK
$720M
| $73.4K | ﹤0.01% |
21,040
+7,712
| +58% | +$28.7K |
|
|
CGAU
11157
Centerra Gold
CGAU
$4.58B
| $73.4K | ﹤0.01% |
10,252
-59,360
| -85% | -$408K |
|
11158
PUT
GrafTech
EAF
$197M
| $73.4K | ﹤0.01% |
5,560
-22,200
| -80% | -$185K |
|
11159
CALL
Seres Therapeutics
MCRB
$51M
| $73.3K | ﹤0.01% |
+3,860
| New | +$78.3K |
|
11160
Forte Biosciences
FBRX
| $73.3K | ﹤0.01% |
13,096
+11,722
| +853% | +$121K |
|
11161
PUT
Champions Oncology
CSBR
$69.3M
| $73K | ﹤0.01% |
+15,000
| New | +$70.3K |
|
11162
PUT
SelectQuote
SLQT
$94.1M
| $72.9K | ﹤0.01% |
33,600
+14,000
| +71% | +$45.9K |
|
11163
Caesarstone
CSTE
$108M
| $72.9K | ﹤0.01% |
+15,988
| New | +$80.5K |
|
11164
AdvisorShares Dorsey Wright Short ETF
DWSH
$5.94M
| $72.9K | ﹤0.01% |
+10,199
| New | +$74.7K |
|
11165
Accuray
ARAY
$32.5M
| $72.9K | ﹤0.01% |
40,474
-98,139
| -71% | -$187K |
|
|
OTLY
11166
CALL
Oatly Group
OTLY
$468M
| $72.7K | ﹤0.01% |
4,275
-13,015
| -75% | -$244K |
|
11167
PUT
Savara
SVRA
$1.09B
| $72.5K | ﹤0.01% |
17,100
-31,200
| -65% | -$138K |
|
|
KNDI
11168
CALL
Kandi Technologies Group
KNDI
$62.5M
| $72.3K | ﹤0.01% |
35,100
-53,200
| -60% | -$96.7K |
|
11169
Protalix BioTherapeutics
PLX
$205M
| $72.2K | ﹤0.01% |
70,817
-87,430
| -55% | -$91.9K |
|
|
ONTF
11170
PUT
DELISTED
ON24
ONTF
| $72.2K | ﹤0.01% |
+11,800
| New | +$73K |
|
11171
Sono-Tek
SOTK
$77.2M
| $72.1K | ﹤0.01% |
17,902
+6,838
| +62% | +$27.7K |
|
11172
Copel
ELPC
$8.32B
| $72K | ﹤0.01% |
11,522
-10,031
| -47% | -$66.1K |
|
11173
Village Farms International
VFF
$361M
| $71.8K | ﹤0.01% |
77,173
-146,297
| -65% | -$150K |
|
11174
Aclaris Therapeutics
ACRS
$883M
| $71.8K | ﹤0.01% |
62,408
-144,192
| -70% | -$177K |
|
11175
PUT
CS Disco
LAW
$279M
| $71.7K | ﹤0.01% |
12,200
-800
| -6% | -$4.46K |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.